New agreement improves access to treatment for New Zealanders
Source: PHARMAC A multiproduct agreement, which took effect on 1 December last year, is delivering significant benefits for patients and the health system – freeing up thousands of infusion hours and helping services run more efficiently. Under the agreement Pharmac is funding five treatments for multiple sclerosis, breast cancer, lung cancer and serious eye conditions. … Read more